Form 4: Ginkgo Bioworks Director Harry Sloan Buys $272,000 in Company Stock

Director Harry Sloan increased his stake in Ginkgo Bioworks by purchasing 297,619 shares of Class A Common Stock at an average price of $0.9133 on May 14, 2024.

Summary

• On May 14, 2024, Harry Sloan, a director of Ginkgo Bioworks Holdings, Inc., purchased 297,619 shares of Class A Common Stock.
• The purchase was made at a weighted average price of $0.9133 per share.
• The total value of the purchase was approximately $271,790.
• Following the transaction, Mr. Sloan directly owns 718,540 shares of Ginkgo Bioworks.
• The purchase was executed under Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director buying shares is generally a good sign, but the document is simply a regulatory filing of the transaction.

Positives

• A director purchasing company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as an indicator of management's confidence in the company's prospects. It can be a positive signal, especially when a director increases their holdings.

Stakeholder Impact

• The purchase could positively influence shareholder sentiment.

Key Dates